Benzoxazoles as Selective Monoamine Oxidase B (MAO-B) Inhibitors

被引：2

作者：

Sawant, Vikram S. ^{[1
,2
]}

Park, Hyeri ^{[1
]}

Baek, Soo Yoon ^{[1
]}

Lee, Jieon ^{[1
,2
]}

Choi, Ji Won ^{[3
]}

Park, Ki Duk ^{[3
]}

Choi, Kyung Il ^{[1
]}

Seong, Jihye ^{[1
,2
,3
]}

Lee, Sanghee ^{[1
]}

Choo, Hyunah ^{[1
,2
]}

机构：

[1] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul 02792, South Korea

[2] Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci & Technol, Seoul 02792, South Korea

[3] Korea Inst Sci & Technol, Convergence Res Ctr Diag Treatment Care Dementia, Seoul 02792, South Korea

来源：

BULLETIN OF THE KOREAN CHEMICAL SOCIETY | 2019年 / 40卷 / 05期

基金：

新加坡国家研究基金会;

关键词：

Parkinson's disease; MAO-B; Selective inhibitor; Benzoxazole; PARKINSONS-DISEASE; SAFINAMIDE;

D O I：

10.1002/bkcs.11704

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：457 / 460

页数：4

共 23 条

[1]

Abell CW, 2001, PROG NUCLEIC ACID RE, V65, P129

[2]

Ayano G., 2016, J MENTAL DISORDERS T, DOI [DOI 10.4172/2471-271X.1000120, 10.4172/2471-271X.1000120]

[3] Safinamide in the management of patients with Parkinson's disease not stabilized on levodopa: a review of the current clinical evidence [J].

Bette, Sagari ;

Shpiner, Danielle S. ;

Singer, Carlos ;

Moore, Henry .

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 :1737-1745

[4] Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs [J].

Binda, Claudia ;

Wang, Jin ;

Pisani, Leonardo ;

Caccia, Carla ;

Carotti, Angelo ;

Salvati, Patricia ;

Edmondson, Dale E. ;

Mattevi, Andrea .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (23) :5848-5852

[5]

Blochberger A., 2011, CLIN PHARM, V3, P361

[6] An inducible MAO-B mouse model of Parkinson's disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics [J].

Chamoli, Manish ;

Chinta, Shankar J. ;

Andersen, Julie K. .

JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (11) :1651-1658

[7] Loss of dopaminoreceptive neuron causes L-dopa resistant parkinsonism in tauopathy [J].

Chiba, Shunmei ;

Takada, Erika ;

Tadokoro, Mamoru ;

Taniguchi, Taizo ;

Kadoyama, Keiichi ;

Takenokuchi, Mariko ;

Kato, Seiya ;

Suzuki, Noboru .

NEUROBIOLOGY OF AGING, 2012, 33 (10) :2491-2505

[8] PHARMACOLOGICAL AND NONPHARMACOLOGICAL INTERVENTIONS IN THE TREATMENT OF PARKINSONS-DISEASE [J].

CUTSON, TM ;

LAUB, KC ;

SCHENKMAN, M .

PHYSICAL THERAPY, 1995, 75 (05) :363-373

[9]

Finberg J. P. M., 2016, FRONT PHARMACOL, V7, P1

[10] Cognitive change in Parkinson disease [J].

Galvin, James E. .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2006, 20 (04) :302-310

← 1 2 3 →